1. Mazzone PJ, Anil V, Andrew C, Frank D, David C, John H, Amos D, Douglas A. Quality indicators for the evaluation of patients with lung cancer. Chest. 2014;146(3):659–69.
2. Ben Amar J, Ben Safta B, Zaibi H, Dhahri B, Baccar MA, Azzabi S. Prognostic factors of advanced stage non-small-cell lung cancer. La Tunisie medicale. 2016;94(5):360–7.
3. Sacco PC, Casaluce F, Sgambato A, Rossi A, Maione P, Palazzolo G, Napolitano A, Gridelli C. Current challenges of lung cancer care in an aging population. Expert Rev Anticancer Ther. 2015;15(12):1419–29.
4. Tawee T, Michelle C, Ji-Hyun L, Fulp WJ, Fred S, Brown RH, Levine RM, Cartwright TH, Guillermo AT, Kim GP. Quality of care in non-small-cell lung cancer: findings from 11 oncology practices in Florida. J. Oncol. Pract. 2011;7(6):e25–31.
5. Chinese Association of Oncologists, Chinese Society for Clinical Cancer Chemotherapy. The Guideline for Diagnosis and Treatment of Chinese Patients with sensitizing EGFR Mutation or ALK Fusion Gene-Positive Non-Small Cell Lung Cancer (2015 Version)[J]. Chin J Oncol. 2015;37(10):796–99.